Rheacell Gmbh & Co. Kg
Clinical trials sponsored by Rheacell Gmbh & Co. Kg, explained in plain language.
-
Breakthrough stem cell therapy enters final testing phase for 'Butterfly Children' disease
Disease control OngoingThis study is testing whether stem cell injections can help heal wounds in people with epidermolysis bullosa, a rare genetic condition that causes extremely fragile skin. Researchers are comparing the stem cell treatment against a placebo in patients aged 6 months and older who h…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Spray-On cells could heal wounds that Won't close
Disease control OngoingThis study is testing a new treatment for chronic leg ulcers that have not healed with standard care. It involves applying a spray containing cells from healthy donors directly to the wound. The goal is to see if this cell therapy can help close these stubborn ulcers and improve …
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Stem cell breakthrough trial offers hope for 'Butterfly Children'
Disease control OngoingThis late-stage trial is testing whether a special type of stem cell (ABCB5+ MSCs) can help heal wounds in people with epidermolysis bullosa (EB), a painful genetic condition that causes fragile, blistering skin. The study involves 91 participants with two severe forms of EB. It …
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC